Personalised Health Care - Fostering Precision Medicine Advancements for Gaining Population Health Impact (Paperback, 1st ed. 2021)

Practitioners are increasingly adopting a personalised medicine approach to individually tailored patient care, especially disease diagnosis and treatment with the use of biomarkers. However, development and implementation of such approaches to chronic disease prevention need further investigation and concerted efforts for proper use in healthcare systems. This book provides high-quality, multidisciplinary knowledge from research in personalised medicine, specifically personalised prevention of chronic disease. It addresses different perspectives of prevention in the field, and is the outcome of a four-year work of the Personalized prevention of Chronic Disease (PRECeDI) Consortium, a multi-disciplinary and multi-professional team of experts. The Consortium jointly agreed to document and address the five aspects or domains of personalised medicine and prevention as individual chapters: Identification of biomarkers for the prevention of chronic disease Evaluation of predictive genomic applications Ethico-legal and policy issues surrounding personalised medicine Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis Identification of organisational models for the provision of predictive genomic applications The book focuses on the Consortium's recommendations that are derived from each of these domains based on up-to-date evidence and research that the authors write, follow, and systematically organise and report. Personalisation of health care is, eventually, a driver of innovation in research and healthcare systems. With this SpringerBrief on Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact, the Consortium provides further evidence of the clinical validity and utility of personalised medicine with special emphasis on the prevention of chronic diseases. The book is a useful resource for policy makers, industry and healthcare professionals, scientists, technology-sector professionals, investors, citizens, and private companies that need proper advice to realise the potential of personalised medicine.

General

Imprint:	Springer Nature Switzerland AG
Country of origin:	Switzerland
Series:	SpringerBriefs in Public Health
Release date:	November 2020
First published:	2021
Editors:	Stefania Boccia • Roza Adany • Paolo Villari • Martina C Cornel • Corrado De Vito • Roberta Pastorino
Dimensions:	235 x 155 x 13mm (L x W x T)
Format:	Paperback
Pages:	120
Edition:	1st ed. 2021
ISBN-13:	978-3-03-052398-5
Categories:	Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics Books > Law > Laws of other jurisdictions & general law > Social law > General Books > Medicine > General issues > Public health & preventive medicine > General Books > Medicine > General issues > Health systems & services > General Books > Humanities > Philosophy > Topics in philosophy > Ethics & moral philosophy > General Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General Books > Philosophy > Topics in philosophy > Ethics & moral philosophy > General
LSN:	3-03-052398-5
Barcode:	9783030523985

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!